Abstract: We report a case of concurrent nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) and classic Hodgkin lymphoma (cHL), of nodular sclerosis subtype, in an otherwise healthy 24-year-old man with a strong family history of cHL. The patient was found to have a parotid mass, which was diagnosed as NLPHL, and a thymic mass diagnosed as cHL, of nodular sclerosis subtype concurrently. The lesion in the parotid showed features typical of NLPHL by morphology and immunophenotype. The LP cells were positive for PAX5, CD20, Oct2, weakly positive for CD30, and negative for CD15. The thymic lesion, diagnosed as cHL, of nodular sclerosis subtype, showed prominent bands of fibrosis and Hodgkin/Reed-Sternberg and lacunar cells positive for CD30 and CD15. These cells were variably positive for CD20 and negative for Oct2. PAX5 was weakly positive. Immunoglobulin gene rearrangement studies by polymerase chain reaction were carried out on microdissected Hodgkin/Reed-Sternberg and LP cells, which were shown to have identically sized peaks. NLPHL and cHL are 2 distinct diseases and are almost never seen concurrently. We present a case in which polymerase chain reaction analysis indicated that the tumor cells of these 2 distinct entities were clonally identical.
N odular lymphocyte predominant Hodgkin lymphoma (NLPHL) and classic Hodgkin lymphoma (cHL) are recognized as 2 distinct entities by the current 2008 World Health Organization (WHO) classification. 26 Both
Hodgkin/Reed-Sternberg (HRS) cells and lymphocytic and histiocytic cells, now termed as lymphocyte predominant (LP) cells, have been well accepted as being of B-cell origin. 17 NLPHL and cHL differ in clinical presentation, immunophenotype, morphology, inflammatory background, and B-cell gene expression program. Clinically, patients with NLPHL most often have localized peripheral lymphadenopathy without associated B symptoms and no mediastinal involvement, whereas cHL of nodular sclerosis (NS) subtype most often presents with a mediastinal mass, with or without cervical lymphadenopathy, and a tendency to spread in a retrograde manner following lymphatic drainage pathways.
NLPHL is associated with an increased risk for progression to diffuse large B-cell lymphoma in 5% to 10% of cases, and both processes may be seen in the same anatomic site. 5, 9, 25 cHL is associated with various forms of B-cell lymphoma at a lower rate. 11 However, finding both NLPHL and cHL concurrently in the same patient is extremely rare. In 1993, Gelb et al 8 reported 1 patient with a composite lymphoma comprising NLPHL and cHL in a single anatomic site, and 4 cases in which NLPHL and cHL were sequential. Herein, we report a case in which NLPHL and cHL, of NS subtype, were diagnosed concurrently in separate anatomic sites; moreover, polymerase chain reaction (PCR) analysis of microdissected tumor cells showed that the 2 lesions were clonally related.
CASE REPORT
The patient is a 24-year-old man with no known significant medical history, who presented with a 9-month history of a right postauricular parotid, nickel-sized mass. The patient denied having fever, chills, night sweats, pruritus, or weight loss. At initial evaluation, the mass was thought to be inflammatory and the patient received a course of antibiotics but the lesion did not decrease in size. The parotid mass was excised and grossly measured to be 3.0 Â 2.4 Â 1.8 cm; it had a "fish flesh" consistency. A diagnosis of NLPHL was made. Computed tomographic and Fludeoxyglucose (18F)-positron emission tomography scans were performed and showed a hypermetabolic thymic mass measuring approximately 2 cm. The thymus was excised and measured to be 9.0 Â 4.5 Â 1.5 cm and weighed 19 g; it contained a nodular lesion measuring 2.0 cm in its largest dimension. The lesion was diagnosed as cHL of NS subtype.
The complete blood count and basic metabolic panel of the patient were within normal limits and he was seronegative for human immunodeficiency virus. A bone marrow aspirate and biopsy were performed and showed a normocellular marrow with no morphologic evidence of lymphoma.
Further inquiry of the family history of the patient was noteworthy. The patient's father had a past history of cHL and had been in complete remission for more than 13 years. His paternal grandfather died at 67 years of age of acute myeloid leukemia and 2 paternal cousins also had a past history of cHL.
MATERIALS AND METHODS
Tissue Samples, Immunohistochemistry, and In Situ Hybridization
The 2 biopsy samples were fixed in 10% neutralbuffered formalin, embedded in paraffin, and stained with hematoxylin and eosin. A panel of immunohistochemical stains were performed using commercially available antibodies, on formalin-fixed paraffin-embedded (FFPE) sections according to previously published techniques (Table 1) . 7, 23 In situ hybridization for EBV encoded RNA (EBER) was performed on FFPE tissue sections using a fluorescein isothiocyanate-labeled oligonucleotide probe supplied by Ventana Medical Systems (Tucson, AZ) on an automated stainer (Ventana Benchmark). Visualization was achieved using the ISH iView system with Alk-Phosphatase and Nitro blue tetrazolium chloride/5-Bromo-4-chloro-3-indolyl phosphate substrate, with Fast red as contrast. A positive control was run with all cases and stained appropriately. 
Laser-assisted Microdissection

Immunoglobulin PCR
DNA extraction was performed on FFPE using a QiaCUBE extraction platform using their proprietary buffer and proteinase K digestion. PCR was performed using consensus primers directed to V H framework (FR) III and the joining region (J H ) of the immunoglobulin heavy-chain gene (FRIII-IGH PCR) and to V H FR region II and the joining region (FRII-IGH PCR), according to the method of Ramasamy et al. 21 Testing for the IGk locus was additionally performed using the Biomed II primer set described by van Dongen et al 29 and supplied by InVivoScribe Technologies (Cat#: 1-102-0031; IGK@ Gene Clonality Assay-ABI Fluorescence Detection). These reactions interrogate rearrangements involving the Vk loci and Jk (tube A), the Vk locus and the kDE locus (tube B), and the k-intron RSS locus and the kDE locus (tube B). The products from all reactions were separated by capillary electrophoresis on an ABI 3130 Â l Genetic Analyzer and the electropherograms were analyzed using GeneMapper software version 3.7 (ABI).
RESULTS
Pathologic Features
A pathologic review of the parotid mass showed effaced architecture by a vaguely nodular infiltrate containing scattered large atypical cells with multilobulated nuclei, vesicular chromatin, and small nucleoli, characteristic of LP cells in a background of small B lymphocytes and histiocytes (Figs. 1A, B) . The LP cells were largely distributed singly, but focally formed small clusters in a vaguely nodular growth pattern. The LP cells were found to be strongly positive for Oct2, PAX5, and CD20 by immunohistochemistry (Table 1 and Figs. 1C, D) . Scattered cells were weakly positive for CD30 but negative for CD15. EBER in situ hybridization was negative. CD3 highlighted characteristic rosetting by small T cells. The numerous background small B cells were positive for CD20 and IgD.
The thymus gland contained a discrete nodule divided by broad fibrous bands and clusters of HRS cells and lacunar cells in a background of small lymphocytes, histiocytes, and eosinophils ( Figs. 2A, B ). There were interspersed Hassall corpuscles and clusters of thymic epithelial cells. These HRS cells were weakly positive for PAX5 (Fig. 2B inset) , variably positive for CD20, and negative for Oct2. They were positive for CD30 and CD15 (Figs. 2C, D) . EBER was negative as well.
Molecular Studies
Immunoglobulin gene rearrangement studies were carried out by PCR for both heavy-chain (IGH@) and k light-chain (IGK@) loci on DNA isolated from wholemount tissue sections. A polyclonal pattern was seen with FRII-IGH and FRIII-IGH for both lesions on wholemount tissue sections. However, the IGK@ primers identified clonal peaks of identical size in DNA from both the NLPHL and cHL samples. To confirm that the clone was derived from neoplastic cells, the PCR reactions were repeated on DNA isolated from microdissected LP cells and HRS cells, respectively (Figs. 3A, B) . The prominent background small B lymphocytes in the case of NLPHL were microdissected as well to determine whether those cells contained the same clonal rearrangement. DNA from the microdissected LP and HRS cells again showed identical clonal rearrangements, whereas the small B cells microdissected in the case of NLPHL were negative for a clonal rearrangement for both IGH@ (not shown) and IGK@ (Fig. 3C) . DNA quantity from laser-assisted microdissection was insufficient for analysis by sequencing.
DISCUSSION
Having concurrent NLPHL and cHL is exceedingly rare (Table 2) . Moreover, other studies have not examined the clonal relationship between the cells of NLPHL and cHL in those cases in which both processes were found in the same patient. Using microdissection techniques, we report a novel case in which we show that LP cells and the classic HRS cells contained the same sized IGK@ gene rearrangement.
In 1993, Gelb et al 8 described a 22-year-old man in whom histologic features of NLPHL and cHL, of mixed cellularity subtype, were identified in a single right submandibular lymph node. The patient achieved complete remission following radiotherapy alone. Those investigators also described 4 other patients in whom the diagnoses of cHL and NLPHL were made sequentially (range, 3 to 18 y). In 3 of the 4 cases, cHL preceded the diagnosis of NLPHL. Miettinen et al 19 reported 2 cases of NLPHL with subsequent biopsies of MCCHL, 5 and 17 years later. None of the other studies included cases with concurrent NLPHL and cHL. In none of the above studies were the investigators able to examine the clonal relatedness of the 2 neoplasms.
LP and HRS cells are now believed to be derived from germinal-center B cells. In cHL, microdissection of HRS cells from frozen tissue sections verified the B-cell origin of the cells, and showed that the IG genes were in a clonal configuration. 15 HRS cells have been postulated to be derived from germinal-center B cells, based on the presence of somatic hypermutation and evidence of intraclonal diversity of the VH genes. LP cells are also known to have clonally rearranged immunoglobulin genes and are believed to be derived from antigen-selected germinal-center B cells.
2,13 BCL6-associated translocations are frequent in LP cells and their frequent expression of BCL-6 by immunohistochemistry is another indication of their germinal-center B-cell origin. 22, 27, 30 NLPHL and cHL are regarded in the WHO classification as separate diseases. A hallmark of cHL is downregulation of the B-cell program, such that most B-cell markers are not expressed in classic HRS cells. Some studies have suggested that NLPHL may be more closely related to the B-cell non-Hodgkin lymphomas. However, a recent study has shown surprising similarities with cHL. 3 Using gene expression profiling of microdissected LP cells, Brune et al 3 showed a close relationship between NLPHL and T-cell/histiocyte-rich large Bcell lymphoma, as anticipated. However, unexpectedly, NLPHL, similar to cHL, showed evidence of suppression of the B-cell program, in contrast to diffuse large B-cell lymphoma, Burkitt lymphoma, or follicular lymphoma. In addition to the diminished expression of B-cell-specific transcription factors, other features shared in common between LP cells and HRS cells were constitutive Nuclear Factor-kB activity and activation of the ERK signaling pathway. The occurrence of both forms of Hodgkin lymphoma in a single patient may be further evidence of a close relationship. In addition, we show that both tumors contained the same-sized IGK@ gene rearrangement, suggesting that NLPHL and cHL might in some cases arise from a common B-cell precursor.
Intriguingly, the patient has a strong family history of cHL. The father and the paternal first and third cousins all had cHL. The paternal grandfather and the first cousin also had acute leukemia. These findings suggest an inherited susceptibility to developing a hematolymphoid neoplasm such as cHL in this family. Kerzin-Storrar et al 12 estimated a 4-fold increase in risk of cHL in firstdegree and second-degree relatives affected with Hodgkin lymphoma. They estimated that 4.5% of cHL may be familial. Interestingly, 4 of the 6 familial Hodgkin cases were seen in a first-degree male relative. This finding was later supported by a study by Bernard et al 1 in which they also found a male predominance in 9 familial Hodgkin cases.
Supporting a role for genetic factors in the development of Hodgkin lymphoma, Mack et al 16 , in a study of 432 twin pairs, found a greater risk for disease in monozygotic (10 of 179 twin pairs) as opposed to dizygotic twin siblings (0 of 187) of patients with Hodgkin lymphoma. As for familial NLPHL, cases have been described infrequently and genetic studies are very limited. 4, 28 In cHL, a clonal result for IG gene rearrangement studies is usually not detected in whole-tissue sections, 6, 10, 14, 18, 20, 24 The lack of clonal IG gene rearrangement in some of these studies is likely due to technical issues related to the success of the microdissection or the primer sets used at that time. In this case, we performed PCR on DNA extracted from complete sections (results not shown) and from DNA isolated from microdissected HRS and LP cells. Using complete tissue sections from both the NLPHL and cHL case, IGH@ showed a polyclonal rearrangement, whereas IGK@ showed 2 distinct peaks of the same size, suggesting a clonal rearrangement. IGK@ performed on microdissected HRS and LP cells identified the same clonal peaks, a finding that further supports the fact that the tumor cells shared the same clonal rearrangement. To rule out the possibility that the small B lymphocytes in the background were the cause of this clone, we microdissected the background B cells, which were polyclonal for IGH@, and no specific peaks were seen with IGK@.
NLPHL and cHL are defined as 2 distinct entities by the WHO classification. They are similar in that they are both of germinal-center B-cell origin, but differ in many other aspects. However, recent data from gene expression profiling have suggested that the 2 entities may be more closely related. 3 Nevertheless, cases of coexisting NLPHL and cHL are exceedingly rare. In the reported case, an increased familial risk may explain the development of both lymphoma subtypes in the same patient.
